BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
Rheumatology Department, Portsmouth NHS Hospitals Trust, Portsmouth.
Jo
J
Ledingham
Rheumatology Department, King's College Hospital NHS Foundation Trust, London.
Nicola
N
Gullick
Rheumatology Department, King's College Hospital NHS Foundation Trust, London.
Katherine
K
Irving
Rheumatology Department, Central Manchester University Hospitals NHS Foundation Trust, Manchester.
Rachel
R
Gorodkin
Rheumatology Department, Central Manchester University Hospitals NHS Foundation Trust, Manchester.
Melissa
M
Aris
National Rheumatoid Arthritis Society, Maidenhead.
Jean
J
Burke
Rheumatology Department, King's College Hospital NHS Foundation Trust, London.
Patrick
P
Gordon
Rheumatology Department, Epsom and St Helier University Hospitals NHS Trust, Epsom.
Dimitrios
D
Christidis
South Brent Health Centre, South Brent, Devon.
Sarah
S
Galloway
North Street Medical Practice, Peterborough.
Eranga
E
Hayes
Rheumatology Department, Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool.
Andrew
A
Jeffries
Department of Pharmacy, Guy's and St Thomas' Hospital NHS Foundation Trust, London.
Scott
S
Mercer
School of Health Sciences, University of East Anglia, Norwich, UK.
Janice
J
Mooney
Rheumatology Department, Radboud University Medical Centre, Nijmegen, Netherlands.
Sander
S
van Leuven
Rheumatology Department, King's College London, London, UK.
James
J
Galloway
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D016903:Drug Monitoring; D011307:Drug Prescriptions; D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy*
D018501:Antirheumatic Agents
DMARDs; co-morbidity; drug toxicity; methotrexate; rheumatic disease; safe prescribing; shared care; treatment monitoring